Thyroid cancer: molecular aspects and new therapeutic strategies. - Wikidata - awgldk - TriplyDB

Thyroid cancer: molecular aspects and new therapeutic strategies.

Thyroid cancer: molecular aspects and new therapeutic strategies.

http://www.wikidata.org/entity/Q36111541

about

Multikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinib Neoadjuvant Therapy in Differentiated Thyroid Cancer Thyroid cancer: SEOM clinical guidelines.Molecular profiling of thyroid cancer subtypes using large-scale text mining.The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients Comprehensive literature review: recent advances in diagnosing and managing patients with poorly differentiated thyroid carcinoma Lenvatinib for Anaplastic Thyroid Cancer.New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: literature review Consensus on the management of advanced radioactive iodine-refractory differentiated thyroid cancer on behalf of the Spanish Society of Endocrinology Thyroid Cancer Working Group (GTSEEN) and Spanish Rare Cancer Working Group (GETHI).Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.Expression of YY1 in Differentiated Thyroid Cancer.High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.Curcumin induces endoplasmic reticulum stress-associated apoptosis in human papillary thyroid carcinoma BCPAP cells via disruption of intracellular calcium homeostasis.

P2860

Q26821959-C8DC5A90-578F-442F-B833-B47AFFF15A89 Q28078879-E2D2F556-9BD9-4A72-BC24-C72B84D8FFC8 Q34553635-CCE60237-5C7F-42C8-A25B-537557BD0781 Q34914970-D85C5236-EC16-47C3-9264-CA1E4ACEB30A Q35932262-62873D9C-BB65-4220-90C8-306906783520 Q36640992-8D9CE32D-1CA9-4096-BCBF-9673159E5870 Q37672425-0BE78E50-0D7F-400C-8594-41476B5726C3 Q38074169-03EE9EB4-CAA2-4156-B289-57A7896E78A8 Q38972528-B241CD1C-DDBC-49D7-B6BD-190393BF5F63 Q40091055-E4E6819D-1813-4523-8AED-0C5D7ABC2429 Q41386769-FD8494EC-A23C-4F7C-B556-DCE7B11E9228 Q46952217-2F1F4322-FE6F-4B56-A355-8170D20DC8A3 Q55446077-74DB1BE3-E880-4DD8-96BA-F26FBEA05F9E

P2860

Thyroid cancer: molecular aspects and new therapeutic strategies.

http://www.wikidata.org/entity/Q36111541

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Thyroid cancer: molecular aspects and new therapeutic strategies.

@ast

Thyroid cancer: molecular aspects and new therapeutic strategies.

@en

type

label

Thyroid cancer: molecular aspects and new therapeutic strategies.

@ast

Thyroid cancer: molecular aspects and new therapeutic strategies.

@en

prefLabel

Thyroid cancer: molecular aspects and new therapeutic strategies.

@ast

Thyroid cancer: molecular aspects and new therapeutic strategies.

@en

P1433

Q36111541-2570CD62-73F1-458A-9796-6D491ED890C7

P1476

Q36111541-D68D49FB-B026-4C78-9161-17D099945863

P2093

Q36111541-8D6BCDF1-694C-4B03-9D20-1E2B39B5C94A

Q36111541-A361FA70-A87A-4762-8932-C9A0C48DA018

Q36111541-D7E38DED-7BBA-45A1-9CA1-1C34A8B5A660

Q36111541-DE887336-2005-4B8B-8CD7-417B320E3484

P2860

Q36111541-01C1325D-A3BC-4BE9-B972-E1C5F09936E3

Q36111541-1A0F59ED-CEB6-4FFD-BBCF-F081254568A6

Q36111541-1CDDE72A-FCC2-4A5E-A48A-90E867ADD599

Q36111541-2AC5698C-2311-4CF4-9339-763D41415012

Q36111541-36520F4B-B380-44C1-A015-328F393A58F1

Q36111541-3AD463C0-596D-456A-8F66-C28E86F06F8C

Q36111541-581CEFA6-F172-441D-A301-E7DB451A4DCA

Q36111541-58500A06-ADE6-4B39-A322-427119F18A7C

Q36111541-6AC91029-6A14-440B-B99D-4F349613051E

Q36111541-6B98A855-890B-41E7-8EE0-6D9B6D45A2A9

P304

Q36111541-BF38788F-96A6-4EEA-8301-4A3654135FB5

P31

Q36111541-E66F1AFB-8B2D-4487-8BA5-1CD413ADFB42

P356

Q36111541-FB6BA184-1BD0-4798-9EE2-366B3DAC4363

P478

Q36111541-C1661521-5077-4C9C-8E6B-2CADFA422AD7

P577

Q36111541-EEEA2502-7BD3-4E05-8226-22CF433A64C5

P5875

Q36111541-9E53A49A-42E8-4106-BD44-68A29515C52A

P698

Q36111541-3D999FCF-3599-4752-B949-0CCC8B16ADCC

P932

Q36111541-C05D40E5-D1AE-45F7-A90F-F61801E22B67

P356

P1433

Journal of Thyroid Research

P1476

Thyroid cancer: molecular aspects and new therapeutic strategies.

@en

P2093

Carles Zafon

http://www.w3.org/2001/XMLSchema#string

Enrique Grande

http://www.w3.org/2001/XMLSchema#string

Jaume Capdevila

http://www.w3.org/2001/XMLSchema#string

Juan José Díez

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.

Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.

Motesanib diphosphate in progressive differentiated thyroid cancer.

Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.

Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

Thyroid cancer: emerging role for targeted therapies.

Pathogenetic mechanisms in thyroid follicular-cell neoplasia.

Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.

P304

847108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/847108

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230590478

http://www.w3.org/2001/XMLSchema#string

P698

22848860

http://www.w3.org/2001/XMLSchema#string

P932

3403487

http://www.w3.org/2001/XMLSchema#string